Other

Software amortization expense

Vertex Pharmaceuticals Software amortization expense remained flat by 0.0% to $7.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $6.30M to $7.80M. Over 2 years (FY 2023 to FY 2025), Software amortization expense shows an upward trend with a 62.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

Rising amortization may indicate significant past investment in digital infrastructure or IT systems.

Detailed definition

The periodic expense recognized for the consumption of capitalized internal-use or external-use software assets. This re...

Peer comparison

Standard operating expense for technology-reliant companies.

Metric ID: other_capitalized_computer_software_amortization1

Historical Data

3 years
 FY'23FY'24FY'25
Value$11.80M$25.20M$31.20M
YoY Change+113.6%+23.8%
Range$11.80M$31.20M
CAGR+62.6%
Avg YoY Growth+68.7%
Median YoY Growth+68.7%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's software amortization expense?
Vertex Pharmaceuticals (VRTX) reported software amortization expense of $7.80M in Q4 2025.
How has Vertex Pharmaceuticals's software amortization expense changed year-over-year?
Vertex Pharmaceuticals's software amortization expense increased by 23.8% year-over-year, from $6.30M to $7.80M.
What is the long-term trend for Vertex Pharmaceuticals's software amortization expense?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's software amortization expense has grown at a 62.6% compound annual growth rate (CAGR), from $11.80M to $31.20M.
What does software amortization expense mean?
The annual cost of using previously developed or purchased software assets.